Avesta Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Avesta Biotech
Avesta Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2002 and has a history of 22 years and four months. Its registered office is in Ut, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.40 M.
Arvind Vijh, Sanjay Vijh, and Sandeep Vijh serve as directors at the Company.
Company Details
-
LocationUt, Chandigarh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2002PTC025432
-
Company No.
025432
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Sep 2002
-
Date of AGM
26 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Avesta Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Vijh
|
Director | 17-Sep-2002 | Current |
|
Sanjay Vijh
|
Director | 29-Aug-2006 | Current |
|
Sandeep Vijh
|
Director | 05-Jun-2022 | Current |
Financial Performance of Avesta Biotech.
Avesta Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avesta Biotech?
In 2021, Avesta Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Osho Laboratories Private LimitedArvind Vijh, Sanjay Vijh and 1 more are mutual person
Charges (Loans)
₹0.40 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jul 2004 | Bank Of India | ₹0.40 M | Open |
How Many Employees Work at Avesta Biotech?
Unlock and access historical data on people associated with Avesta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avesta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avesta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
